Your browser doesn't support javascript.
loading
Zebrafish as a preclinical in vivo screening model for nanomedicines.
Sieber, Sandro; Grossen, Philip; Bussmann, Jeroen; Campbell, Frederick; Kros, Alexander; Witzigmann, Dominik; Huwyler, Jörg.
Affiliation
  • Sieber S; Division of Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
  • Grossen P; Division of Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
  • Bussmann J; Department of Supramolecular and Biomaterials Chemistry, Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands.
  • Campbell F; Department of Supramolecular and Biomaterials Chemistry, Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands.
  • Kros A; Department of Supramolecular and Biomaterials Chemistry, Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands.
  • Witzigmann D; Division of Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland; Department of Biochemistry and Molecular Biology, University of British Columbia, Health Sciences Mall, Vancouver, British Columbia, Canada.. Electronic address: dominik.witzigmann@
  • Huwyler J; Division of Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland. Electronic address: joerg.huwyler@unibas.ch.
Adv Drug Deliv Rev ; 151-152: 152-168, 2019.
Article in En | MEDLINE | ID: mdl-30615917

Full text: 1 Database: MEDLINE Main subject: Disease Models, Animal / Nanomedicine / Neoplasms Type of study: Diagnostic_studies / Screening_studies Limits: Animals Language: En Journal: Adv Drug Deliv Rev Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2019 Type: Article Affiliation country: Switzerland

Full text: 1 Database: MEDLINE Main subject: Disease Models, Animal / Nanomedicine / Neoplasms Type of study: Diagnostic_studies / Screening_studies Limits: Animals Language: En Journal: Adv Drug Deliv Rev Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2019 Type: Article Affiliation country: Switzerland